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[Introduction]: Much effort is dedicated to the development of herbal therapeutics in 
cancer. Extracts from common herbs possess bioactivities such as antioxidant or anti-
inflammatory properties, and natural supplements with antioxidant activity have been 
reported to reduce the incidence or mortality of gastrointestinal tumors. However, 
different antioxidants display different effects and clinical trials are controversial, maybe 
due to the lack of knowledge of their specific mechanism of action.  
[Methods]: Supercritical fluid extracted herbs with known antioxidant activity (HE) were 
used to analyze their effect on human colon cancer cells and determine its mechanism of 
action. Antiproliferative effect was analyzed by MTT assay in SW620 and HT-29 cells 
determining growth inhibition (GI50), citostacity (TGI50) and citotoxicity (LC50). 
Anchorage-independent growth assays were performed for cell transformation. Gene 
expression and ontology analysis after HE treatment were developed under different 
conditions according to the biological effects using Agilent G4112F Whole Human Genome 
Microarray and Ingenuity Pathways Analysis.  
[Results]: HE exhibited dose-dependent viability suppression and inhibition of cell 
transformation. Gene expression analysis revealed that the most significant altered 
network was involved in cell death and protein degradation. Lipid and carbohydrate 
metabolism-related genes were also altered with a greater score than those related to 
oxidative stress or inflammatory response, suggesting a stronger effect of HE in tumors in 
which these networks are involved.  
[Conclusions]: Phytochemical compounds display bioactivities pointing at them as 
promising supplements in nutritional-related diseases such as colon cancer. However, not 
all antioxidant phytochemicals are beneficial for all patients, and the analysis of the 
specific mechanism of action of each compound is necessary for including them in 
personalized treatments. Nutrigenomic analysis of phytochemical- induced modulation of 
gene expression is a powerful tool for understanding the biological effect of these 
products, and might result in an improvement of personalized therapies of cancer 
patients. 
